M&A Deal Summary

Solta Medical and Medicis Pharmaceutical Acquire LipoSonix

On June 16, 2008, Solta Medical and Medicis Pharmaceutical acquired medical products company LipoSonix from Three Arch Partners and EW Healthcare Partners for 150M USD

Acquisition Highlights
  • This is Solta Medical’s 1st and Medicis Pharmaceutical’s 1st transaction in the Medical Products sector.
  • This is Solta Medical’s and Medicis Pharmaceutical’s 2nd largest (disclosed) transaction.
  • This is Solta Medical’s 1st and Medicis Pharmaceutical’s 2nd transaction in the United States.
  • This is Solta Medical’s 1st and Medicis Pharmaceutical’s 1st transaction in California.

M&A Deal Summary

Date 2008-06-16
Target LipoSonix
Sector Medical Products
Buyer(s) Solta Medical
Medicis Pharmaceutical
Sellers(s) Three Arch Partners
EW Healthcare Partners
Deal Type Add-on Acquisition
Deal Value 150M USD

Target

LipoSonix

California, United States
LipoSonix is developing technology for noninvasive cosmetic surgery applications. LipoSonix was acquired by Medicis Pharmaceutical.

Search 201,893 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Solta Medical

Hayward, California, United States

Category Company
Founded 1996
Sector Medical Products
Employees371
DESCRIPTION

Solta Medical is a designer, developer, manufacturer and marketer of medical devices for the non-invasive treatment of wrinkles. Solta Medical was formed in 1996 and is based in Hayward, California.


DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 3
Type (Add-on Acquisition) 1 of 3
State (California) 1 of 2
Country (United States) 1 of 3
Year (2008) 1 of 1
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-26 Aesthera

Pleasanton, California, United States

Aesthera Corp. is a developer, manufacturer and marketer light-based aesthetic treatment systems based on proprietary photopneumatic technology that is more effective than currently available methods for hair removal, skin rejuvenation and treatment of vascular and pigmented lesions.

Buy -
Buyer

Medicis Pharmaceutical

Scottsdale, Arizona, United States

Category Company
Founded 1987
Sector Life Science
Employees646
DESCRIPTION

Medicis Pharmaceutical Corporation is a pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions.


DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 3
State (California) 1 of 1
Country (United States) 2 of 3
Year (2008) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-10-01 Ascent Pediatrics

Wilmington, Massachusetts, United States

Ascent Pediatrics, Inc. - developed and marketed pharmaceutical products exclusively for the pediatric market, tailoring existing drug compounds to meet the specific needs of the pediatric market, which include improving both taste and delivery methodology.

Buy $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-20 Graceway Pharmaceuticals

Bristol, Tennessee, United States

Graceway Pharmaceuticals, Inc. (Graceway), headquartered in Bristol, Tennessee, is a pharmaceutical company focused on acquiring, in-licensing, and developing branded prescription pharmaceutical products.

Buy $455M

Seller(S) 2

SELLER

Three Arch Partners

San Mateo, California, United States

Category Private Equity Firm
Founded 1993
PE ASSETS 1.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Three Arch Partners is an investor in healthcare companies, including medical devices, diagnostics, and healthcare services. Three Arch primarily invests in early stage companies, however the Firm will consider select later stage investments. Three Arch typically invests alongside others and looks to commit $100k to $15 million per investment. Three Arch Partners was formed in 1993 and is based in San Mateo, California.


DEAL STATS #
Overall 8 of 24
Sector (Medical Products) 6 of 14
Type (Add-on Acquisition) 6 of 16
State (California) 6 of 17
Country (United States) 8 of 24
Year (2008) 1 of 1
Size (of disclosed) 6 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-01 Cameron Health

San Clemente, California, United States

Cameron is developing a next generation leadless implantable cardiac defibrillator . Cameron Health company headquartered in San Clemente, California. Founded in 2001, the company has developed the world's first and only commercially available completely subcutaneous ICD (S-ICD System).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-07-01 Voyage Medical

Tempe, Arizona, United States

Voyage Medical is developing a medical imaging and therapeutic technology that will transform therapy in percutaneous intracardiac procedures. The innovative platform addresses a common need, one especially important for complex medical procedures – to see what you are doing. Voyage Medical is based in Tempe, Arizona.

Buy -
SELLER

EW Healthcare Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


DEAL STATS #
Overall 12 of 53
Sector (Medical Products) 5 of 24
Type (Add-on Acquisition) 6 of 34
State (California) 4 of 17
Country (United States) 11 of 46
Year (2008) 3 of 5
Size (of disclosed) 17 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-02 ROX Medical

San Clemente, California, United States

ROX Medical is an early phase medical device company that is pioneering an innovative treatment for Hypertension and Chronic Obstructive Pulmonary Disease (COPD).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-08-05 Iomai

Gaithersburg, Pennsylvania, United States

Developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without injections.

Sell €75M